Gender Identity and Expression
More than a year ago, the Government of Canada amended the Canadian Human Rights Act (Bill C-16) to add gender identity and gender expression to the list of prohibited grounds of discrimination. As Kathryn Bird of the law firm Hicks Morley wrote at that time, this amendment would bring “greater awareness of a person’s right to be accommodated, and of the importance of ensuring employers/service providers create an atmosphere conducive to the promotion and productivity of – and delivery of service to – all persons, regardless of gender identity and gender expression.”
Vice President, Client Experience – Erin Gunn
Customers have always been at the core of our business and that’s why our team is always looking for innovation and new ways to delight and exceed client expectations of service and expertise across all of our lines of business.
To ensure we reach our goal of continual improvement, we are pleased to announce the promotion of Erin Gunn to the role of Vice President, Client Experience. In addition to leading the execution and management of our customer experience strategy, Erin will continue to […]
At the close of last year, the Quebec government passed Bill 92, An Act to extend the powers of the Régie de l’assurance maladie du Québec and to amend various legislative provisions.
Among the eighty-four amendments contained in Bill 92, is the requirement for pharmacies to detail drug cost, markup, and dispensing and/or professional fees on the pharmacy receipt.
A consumer website has been created to help Quebec residents understand the new and more detailed pharmacy receipts.
While this kind of detailed breakdown is common practice in other Canadian provinces, it is new […]
The Patented Medicines Regulations, those rules that govern the pricing of pharmaceuticals in Canada, are about to change. Many would suggest that it’s about time. There have been no substantive changes in over 20 years and Canada pays some of the highest drug prices when compared to countries of the Organisation for Economic Co-operation and Development (OECD). The United States and Mexico are the only two OECD countries that have higher patented drug prices than Canada.
The government’s proposal, titled Protecting Canadians from Excessive Drug Prices, sets out amendments to the current drug pricing regulations and may […]